Authors
Manasi Agrawal, Shirley Cohen‐Mekelburg, Maia Kayal, Jordan Axelrad, Jonathan Galati, Brad Tricomi, Kanika Kamal, Adam S Faye, Paul Abrudescu, Ellen Scherl, Garrett Lawlor, Keith Sultan, Dana Lukin, Jean‐Frederic Colombel, Ryan C Ungaro
Publication date
2019/3
Journal
Alimentary pharmacology & therapeutics
Volume
49
Issue
5
Pages
564-571
Description
Background
Race, ethnicity and socio‐economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their impact on disability has not been studied.
Aim
To determine the association between race, ethnicity and socio‐economic factors with disability in IBD, using the validated IBD disability index (IBD‐DI).
Methods
Ambulatory IBD patients were enrolled at five academic centres participating in the New York Crohn's and Colitis Organization. We assessed the IBD‐DI, and collected clinical and socio‐economic data. Factors associated with moderate‐to‐severe disability (IBD‐DI score > 35) on univariable analysis were tested in multivariable models with adjusted odds ratios (aOR) and 95% confidence intervals (CI) reported.
Results
In this study, 323 patients (57.3% CD, 51.4% female) were enrolled; 17.7% were Hispanic, 17% were non‐Hispanic black, 56.0% were non …
Scholar articles
M Agrawal, S Cohen‐Mekelburg, M Kayal, J Axelrad… - Alimentary pharmacology & therapeutics, 2019